These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24741029)

  • 1. Prognostic evaluation of feline mammary carcinomas: a review of the literature.
    Zappulli V; Rasotto R; Caliari D; Mainenti M; Peña L; Goldschmidt MH; Kiupel M
    Vet Pathol; 2015 Jan; 52(1):46-60. PubMed ID: 24741029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline Invasive Mammary Carcinomas: Prognostic Value of Histological Grading.
    Dagher E; Abadie J; Loussouarn D; Campone M; Nguyen F
    Vet Pathol; 2019 Sep; 56(5):660-670. PubMed ID: 31113336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis.
    Mills SW; Musil KM; Davies JL; Hendrick S; Duncan C; Jackson ML; Kidney B; Philibert H; Wobeser BK; Simko E
    Vet Pathol; 2015 Mar; 52(2):238-49. PubMed ID: 25060990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis.
    Seixas F; Palmeira C; Pires MA; Bento MJ; Lopes C
    Vet J; 2011 Jan; 187(1):65-71. PubMed ID: 19955006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
    Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
    Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic histopathological and molecular markers in feline mammary neoplasia.
    Hughes K; Dobson JM
    Vet J; 2012 Oct; 194(1):19-26. PubMed ID: 22841451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.
    Dagher E; Abadie J; Loussouarn D; Fanuel D; Campone M; Nguyen F
    BMC Vet Res; 2019 Jan; 15(1):25. PubMed ID: 30630524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.
    Millanta F; Calandrella M; Citi S; Della Santa D; Poli A
    Vet Pathol; 2005 Jan; 42(1):30-4. PubMed ID: 15657269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of E-cadherin and β-catenin and high expression of basal cytokeratins in feline mammary carcinomas with regional metastasis.
    Peñafiel-Verdu C; Buendia AJ; Navarro JA; Ramirez GA; Vilafranca M; Altimira J; Sanchez J
    Vet Pathol; 2012 Nov; 49(6):979-87. PubMed ID: 22337774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of immunoexpression of claudin-1 and claudin-7 in feline mammary carcinomas.
    Flores AR; Rêma A; Carvalho F; Lopes G; Faustino A; Dias Pereira P
    J Comp Pathol; 2014 Nov; 151(4):339-46. PubMed ID: 25246182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of claudin-2 is associated with high histological grade and metastasis of feline mammary carcinomas.
    Flores AR; Rêma A; Carvalho F; Faustino A; Dias Pereira P
    J Comp Pathol; 2014; 150(2-3):169-74. PubMed ID: 24220012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.
    Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R
    Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
    Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
    Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feline HER2 protein expression levels and gene status in feline mammary carcinoma: optimization of immunohistochemistry (IHC) and in situ hybridization (ISH) techniques.
    Soares M; Correia J; Rodrigues P; Simões M; de Matos A; Ferreira F
    Microsc Microanal; 2013 Aug; 19(4):876-82. PubMed ID: 23718944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosis.
    Millanta F; Lazzeri G; Mazzei M; Vannozzi I; Poli A
    Vet Pathol; 2002 Jan; 39(1):120-6. PubMed ID: 12102203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-cadherin expression in feline mammary tumors is associated with a reduced E-cadherin expression and the presence of regional metastasis.
    Buendia AJ; Peñafiel-Verdu C; Navarro JA; Vilafranca M; Sanchez J
    Vet Pathol; 2014 Jul; 51(4):755-8. PubMed ID: 24091815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of prognostic factors and survival rates in malignant feline mammary gland neoplasms.
    De Campos CB; Damasceno KA; Gamba CO; Ribeiro AM; Machado CJ; Lavalle GE; Cassali GD
    J Feline Med Surg; 2016 Dec; 18(12):1003-1012. PubMed ID: 26460079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feline mammary adenocarcinoma: tumor size as a prognostic indicator.
    Viste JR; Myers SL; Singh B; Simko E
    Can Vet J; 2002 Jan; 43(1):33-7. PubMed ID: 11802667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex carcinomas of the mammary gland in cats: pathological and immunohistochemical features.
    Seixas F; Pires MA; Lopes CA
    Vet J; 2008 May; 176(2):210-5. PubMed ID: 17459738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.